| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/28/2023 | 8.59% | Needham | $105 → $107 | Maintains | Buy |
| 04/28/2023 | 6.56% | Needham | $108 → $105 | Maintains | Buy |
| 01/27/2023 | 17.72% | Sidoti & Co. | → $116 | Upgrades | Neutral → Buy |
| 01/27/2023 | -12.73% | JP Morgan | $90 → $86 | Maintains | Underweight |
| 01/27/2023 | 9.6% | Needham | $112 → $108 | Maintains | Buy |
| 01/17/2023 | 17.72% | Sidoti & Co. | → $116 | Downgrades | Buy → Neutral |
| 10/28/2022 | 16.7% | Raymond James | $105 → $115 | Maintains | Outperform |
| 10/28/2022 | 13.66% | Needham | $105 → $112 | Maintains | Buy |
| 08/29/2022 | 6.56% | Benchmark | $101 → $105 | Maintains | Buy |
| 08/12/2022 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 07/29/2022 | 6.56% | Raymond James | $100 → $105 | Maintains | Outperform |
| 07/29/2022 | 6.56% | Needham | $93 → $105 | Maintains | Buy |
| 07/27/2022 | -0.55% | Benchmark | → $98 | Initiates Coverage On | → Buy |
| 06/07/2022 | 1.48% | Raymond James | → $100 | Upgrades | Market Perform → Outperform |
| 04/29/2022 | -5.62% | Needham | $90 → $93 | Maintains | Buy |
| 01/28/2022 | -8.67% | Needham | $95 → $90 | Maintains | Buy |
| 01/19/2022 | -3.59% | Needham | $105 → $95 | Maintains | Buy |
| 10/29/2021 | 6.56% | Needham | $108 → $105 | Maintains | Buy |
| 08/23/2021 | 11.63% | Fox Advisors | → $110 | Upgrades | Equal-Weight → Overweight |
| 06/22/2021 | 11.63% | Sidoti & Co. | → $110 | Upgrades | Neutral → Buy |
| 06/11/2021 | 6.56% | Loop Capital | $100 → $105 | Maintains | Buy |
| 05/25/2021 | 11.63% | Needham | $102 → $110 | Maintains | Buy |
| 04/23/2021 | 3.51% | Needham | $89 → $102 | Maintains | Buy |
| 03/31/2021 | -4.61% | Sidoti & Co. | → $94 | Downgrades | Buy → Neutral |
| 01/22/2021 | -9.68% | Needham | $77 → $89 | Maintains | Buy |
| 08/12/2020 | -20.84% | JP Morgan | → $78 | Downgrades | Overweight → Neutral |
| 07/24/2020 | -18.81% | Stifel | $60 → $80 | Maintains | Hold |
| 07/24/2020 | -16.79% | Needham | $67 → $82 | Maintains | Buy |
| 04/15/2020 | -26.93% | JP Morgan | $67 → $72 | Maintains | Overweight |
| 03/24/2020 | -32.01% | Needham | $80 → $67 | Maintains | Buy |
| 03/09/2020 | -14.76% | JP Morgan | → $84 | Upgrades | Neutral → Overweight |
| 02/28/2020 | — | Raymond James | Initiates Coverage On | → Market Perform | |
| 01/24/2020 | -15.77% | Sidoti & Co. | $72 → $83 | Maintains | Neutral |
| 01/24/2020 | -10.7% | Needham | $80 → $88 | Reiterates | → Buy |
| 10/25/2019 | — | Sidoti & Co. | Downgrades | Buy → Neutral | |
| 03/20/2019 | — | Sidoti & Co. | Initiates Coverage On | → Buy |
What is the target price for Plexus (PLXS)?
The latest price target for Plexus (NASDAQ: PLXS) was reported by Needham on July 28, 2023. The analyst firm set a price target for $107.00 expecting PLXS to rise to within 12 months (a possible 8.59% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Plexus (PLXS)?
The latest analyst rating for Plexus (NASDAQ: PLXS) was provided by Needham, and Plexus maintained their buy rating.
When is the next analyst rating going to be posted or updated for Plexus (PLXS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Plexus, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Plexus was filed on July 28, 2023 so you should expect the next rating to be made available sometime around July 28, 2024.
Is the Analyst Rating Plexus (PLXS) correct?
While ratings are subjective and will change, the latest Plexus (PLXS) rating was a maintained with a price target of $105.00 to $107.00. The current price Plexus (PLXS) is trading at is $98.54, which is out of the analyst's predicted range.